多分次常规放疗对疼痛性无并发症骨转移的疗效:系统综述
该系统综述检索了多个数据库,纳入17项研究进行定量合成,分析不同多分次放疗(MFRT)剂量下的疼痛缓解率与副作用。结果显示22.5Gy/5的总体缓解率最高,30Gy/15的完全缓解率更好,20Gy/2的部分缓解率更好,但各方案间胃肠道毒性、恶心和呕吐无明显差异。结论认为所研究的分次方案之间无重大差异,与随机数据一致,即骨转移放疗止痛无剂量反应关系。
要点
- 22.5Gy/5的总体缓解率最高,30Gy/15完全缓解率更好,20Gy/2部分缓解率更好。
- 仅4项研究直接比较MFRT剂量,结果不一致,无一致优势方案。
- 各MFRT剂量间胃肠道毒性、恶心和呕吐无明显差异。
核心结论
- 所研究的分次方案之间无重大差异,与随机数据一致,即骨转移放疗止痛无剂量反应关系。
研究设计与样本
- 系统综述,检索Ovid MEDLINE、Embase和Cochrane Central Register of Controlled Trials,从3719篇文章中纳入17项研究进行定量合成。
主要发现
- 22.5Gy/5的总体缓解率最高,30Gy/15的完全缓解率更好,20Gy/2的部分缓解率更好。
- 17项研究中仅4项直接比较MFRT剂量:一项报告24Gy/6的总体缓解略优于20Gy/2;另一项发现20Gy/10的总体缓解略优于30Gy/15和22.5Gy/5。
- 两项随机试验比较20Gy/5与30Gy/10,一项支持20Gy/5,另一项认为30Gy/10更优。
- 各MFRT剂量间胃肠道毒性、恶心和呕吐的总体发生率无大的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation therapy is effective for painful uncomplicated bone metastases, with multiple fraction radiation therapy (MFRT) administered frequently. The optimal dose for MFRT to yield maximum pain relief remains unclear. The aim of this systematic review was to determine pain response across MFRT doses. METHODS: A literature search was conducted in Ovid MEDLINE(R) <1946 to July Week 3 2016>, Embase Classic & Embase <1947 to 2016Week 30> and Cochrane Central Register of Controlled Trials <June 2016>. Pain response rates and the side effects for MFRT doses were extracted. RESULTS: From the 3719 articles identified from the search, 17 were included for quantitative synthesis. 22.5Gy/5 had the highest overall response (OR) rate, 30Gy/15 had better complete response (CR) rate and 20Gy/2 had better partial response (PR) rate. Only 4 of the 17 included studies directly compared MFRT doses with each other - one reported marginally-better OR for 24Gy/6 over 20Gy/2; another found 20Gy/10 to be slightly more efficacious than 30Gy/15 and 22.5Gy/5 for OR. Two randomized trials compared 20Gy/5 and 30Gy/10 - one favored 20Gy/5 while the other concluded 30Gy/10 to be the better option. The overall rate of GI toxicities, nausea, and vomiting did not differ greatly between MFRT doses. CONCLUSION: No major difference exists between the schedules and toxic events studied in these trials. This is consistent with the wealth of randomized data which show no dose response for pain relief after radiotherapy for metastatic bone pain.
引用
- Chow R, Hoskin P, Chan S, et al. Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review. Radiother Oncol. 2017. PMID: 28089482. doi:10.1016/j.radonc.2016.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。